FL S1198

Revises definition of "addiction medicine specialist" to include board-certified psychiatrists instead of physiatrists, and expands "board-certified pain management physician" to include physicians with board certification or subcertification in pain management by the American Board of Medical Specialties.

Expands definition of "chronic nonmalignant pain" to include pain from sickle cell anemia in addition to cancer and rheumatoid arthritis, and requires physicians prescribing controlled substances for such pain to comply with specified standards of practice and registration requirements.

Establishes that prescriptions received by a pharmacy are deemed compliant with standards of practice and valid for dispensing, and exempts certain physicians (anesthesiologists, psychiatrists, rheumatologists, neurologists, hospice and palliative medicine physicians, hospitalists, and those in approved clinical trials) from the controlled substance prescribing standards.

Requires pain-management clinics to register with the Department of Health unless owned by qualified physicians or organized as physician-owned group practices, and provides exemptions for clinics owned by physicians meeting specified residency and practice requirements in pain medicine.

Exempts pharmacists and health care practitioners from reporting controlled substance dispensing to the prescription drug monitoring program when administering to patients receiving hospice care or at licensed medical facilities, and grants pharmacy and prescriber access to patient prescription history in the monitoring program database.